Quick Answer
Emergent BioSolutions Inc. reported Net Income of -$190.60 million for fiscal year 2024.
Emergent BioSolutions Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2024 | -$190.60M | +74.9% |
| 2023 | -$760.50M | -259.4% |
| 2022 | -$211.60M | -196.4% |
| 2021 | $219.50M | -28.1% |
| 2020 | $305.10M | +459.8% |
| 2019 | $54.50M | -13.1% |
| 2018 | $62.70M | -24.1% |
| 2017 | $82.60M | +59.5% |
| 2016 | $51.80M | -17.6% |
| 2015 | $62.87M | +71.1% |
| 2014 | $36.74M | +18.0% |
| 2013 | $31.14M | +32.4% |
| 2012 | $23.52M | +2.2% |
| 2011 | $23.02M | -55.5% |
| 2010 | $51.70M | +66.0% |
| 2009 | $31.14M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $51.20M | -55.4% | +526.7% |
| June 30, 2025 | -$12.00M | +95.8% | -117.6% |
| March 31, 2025 | $68.00M | +655.6% | -40.8% |
| September 30, 2024 | $114.80M | +143.6% | +140.6% |
| June 30, 2024 | -$283.10M | -8.3% | -3245.6% |
| March 31, 2024 | $9.00M | +104.8% | +103.4% |
| September 30, 2023 | -$263.40M | -202.4% | -0.8% |
| June 30, 2023 | -$261.40M | -394.1% | -40.4% |
- Emergent BioSolutions Inc. showed an increase of +74.9% in Net Income compared to the prior fiscal year.
- Over the 2009–2024 period, Emergent BioSolutions Inc.’s net income has declined by 712.0% (from $31.14 million to -$190.60 million).
- The most recent figure is from Emergent BioSolutions Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 4, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: